<div><strong>Help Cassandra Davis Fight for Her Life </strong>
</div>
<div><br />
</div>
<div>Our beautiful, strong, and fiercely loving friend Cassandra Davis is in the fight of her life. At just 32 years old, she is a proud new mother to her 3-year-old son, Paxton, and recently married to the love of her life. Her world should be full of beginnings - not battles.
</div>
<div><br />
</div>
<div><strong>A Rare and Aggressive Cancer</strong>
</div>
<div>In 2021, while pregnant with Paxton, Cassandra’s routine lab work raised red flags. That lab work led to a life-changing discovery: a massive tumor on her adrenal gland. She was diagnosed with adrenocortical carcinoma (ACC) - an extremely rare and aggressive cancer that affects only 1 to 2 people per million each year. It often goes undetected until it's too late. In Cassandra’s case, her son helped save her life before he was even born.
</div>
<div><br />
</div>
<div>At 5 months pregnant, Cassandra underwent surgery to remove the tumor. She delivered Paxton soon after and bravely began radiation therapy. For a year, she remained stable, and we all had hope that remission might be possible.
</div>
<div><br />
</div>
<div>But in January 2024, scans revealed that a lesion in her lung had grown. A biopsy confirmed the cancer had spread - her disease had metastasized. Instead of moving to more intensive treatment, her medical team at Kaiser Permanente placed her on oral chemotherapy and delayed any follow-up imaging for nine months.
</div>
<div><br />
</div>
<div>By the time she was rescanned, the cancer had rapidly progressed. She was now facing Stage IV cancer, with multiple tumors in her lungs and trachea.
</div>
<div><br />
</div>
<div><strong>She Chose the Hardest Path — And Kept Going</strong>
</div>
<div>After learning the cancer had continued to grow unchecked, Cassandra chose to pursue the most aggressive treatment available: multi-agent intravenous chemotherapy, including the drug commonly referred to as the “Red Devil.”
</div>
<div><br />
</div>
<div>The “Red Devil,” or Doxorubicin, is one of the most potent chemo drugs available. Known for its deep red color and harsh side effects, it attacks fast-growing cancer cells but can also cause serious damage to the heart, immune system, and overall health. It’s often used when the cancer is aggressive and other treatments have failed.
</div>
<div><br />
</div>
<div>Over four intense cycles, Cassandra underwent a combination of three chemotherapy drugs. She lost her hair. She lost her appetite. Her energy faded. She spent more time in bed than out. But she never lost her fight. She continued to show up to every appointment. She held onto her faith. She stayed present for her son, even on the hardest days.
</div>
<div><br />
</div>
<div>Then came the next scan: no improvement. None of the tumors had shrunk or disappeared.
</div>
<div><br />
</div>
<div>That’s when her care team at Kaiser told her they had “run out of options.”
</div>
<div><br />
</div>
<div><strong>Immunotherapy Is Not Enough</strong>
</div>
<div>Her doctors placed her back on the original oral chemotherapy and started her on immunotherapy — not to shrink the cancer, but to help boost her immune system just enough to keep her body going. It is not a cure. It is not fighting the disease directly. It’s simply a support in the background — and time is not on our side.
</div>
<div><br />
</div>
<div><strong>Denied a Lifesaving Referral</strong>
</div>
<div>Cassandra and her family have pleaded for a second opinion or access to a more advanced care team at UCSF Medical Center — one of the top cancer institutions in the country. UCSF is listed as a Kaiser affiliate hospital on the Kaiser Website, and their own UCSF website confirms that Kaiser insurance is accepted with referral.
</div>
<div><br />
</div>
<div>Yet her oncologist stated flatly:
</div>
<div><br />
</div>
<div>“Kaiser is not going to want to foot the bill for you to be seen outside of our network.”
</div>
<div><br />
</div>
<div>Every day without action is a missed opportunity. This isn’t a technicality - it’s a system failing a young mother who still has so much to live for.
</div>
<div><br />
</div>
<div><strong>Why We’re Raising Funds</strong>
</div>
<div><strong><em>Cassandra is being denied access to critical second opinions and treatment options that could extend or even save her life. </em></strong>We are raising funds to help her break through this medical dead end and seek care at UCSF or other expert cancer centers outside the Kaiser system.
</div>
<div><br />
</div>
<div><strong>Your donation will help cover:</strong>
</div>
<div><br />
</div>
<ul>
<li>Second opinions and consultations
</li>
<li>Out-of-pocket imaging, labs, or genetic testing
</li>
<li>Travel and lodging for treatment
</li>
<li>Any medications not covered by Kaiser
</li>
<li>Advocacy support 
</li>
</ul>
<div><br />
</div>
<div>This isn’t just about Cassandra - it’s about standing up for anyone who has ever been told “no” when fighting for their life.
</div>
<div><br />
</div>
<div><strong>How You Can Help</strong>
</div>
<div>Please consider donating. Any amount helps and will go directly to Cassandra’s care. If you’re unable to give right now, please share her story with your network. Awareness matters.
</div>
<div><br />
</div>
<div>Cassandra is a mother, a wife, a friend, and a fighter. She is not giving up — and neither are we. Thank you for standing beside her during the most critical moment of her life.
</div>
<div><br />
</div>
<div>With deep gratitude,
</div>
<div>— Friends and Family of Cassandra Davis
</div>

Kristin Chandler

Devon Galbraith

Donovan Staley

Nick Galbraith

Jazmin Escalera

Sierra Hauser

Trisha Boyd

Cameron Castaneda

Christine Horne

Anonymous

Alanna Butler

mitchell galbraith

Ryan Prescott

Shalyn Rodriguez

Lynne Prescott

Patrick Galbraith

Sheila Lanni

Amaria Davis

Jordan Taitano

John Thompson

Donate to Give Cassandra a Fighting Chance

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

Eligible for Profile Share Badge

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

isEligibleForProfileBadge

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Donate to Give Cassandra a Fighting Chance

Still $4,310 to go. Help us build momentum.